Association between liver enzymes and metabolic syndrome in Canadian adults: results from the Canadian health measures survey - cycles 3 &4
- PMID: 36404860
- PMCID: PMC9672191
- DOI: 10.1007/s40200-022-01124-x
Association between liver enzymes and metabolic syndrome in Canadian adults: results from the Canadian health measures survey - cycles 3 &4
Abstract
Background: The relationship between liver enzymes and Metabolic Syndrome (MetS) in different populations, including Canadians, is not consistent and well understood. We used the Canadian Health Measures Survey data (Cycles 3 and 4) to examine the cross-sectional relationships between select liver biomarkers and MetS in the adult Canadian population. The biomarkers selected were gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), and alkaline phosphatase (ALKP).
Methods: Fasting blood samples (FBS) were collected from adults above the age of 20 years for Cycle 3 and Cycle 4 (n = 3003). MetS was diagnosed if the subjects had three or more risk determinants according to the Joint Interim Statement criteria. Primary risk factors included quartile cut-offs for each of the biomarkers ALKP, AST, GGT for males and females separately. A multivariable logistic regression technique based on a maximum likelihood approach was used to evaluate the association between quartiles of ALKP, AST, and GGT, other individual and contextual factors, and the prevalence of MetS.
Results: MetS was prevalent in 32.3% of subjects. BMI was an effect modifier in the relationship between GGT and MetS prevalence, while sex was an effect modifier in the relationship between ALKP and MetS prevalence; and age was an effect modifier in the relationship between AST and MetS prevalence.
Conclusions: Since the mechanisms to underpin the associations between the liver enzymes activity and MetS are unknown, further epidemiologic investigations using longitudinal designs are necessary to understand these associations.
Keywords: Adults; Liver enzymes; Metabolic syndrome; Risk factors.
© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestThe authors declare no competing interests. The authors declare no conflict of interest. The funders had no role in the collection, analyses, or interpretation of data, or in the writing of the manuscript.
Figures



Similar articles
-
The associations between liver enzymes and the risk of metabolic syndrome in the elderly.Exp Gerontol. 2018 Jun;106:132-136. doi: 10.1016/j.exger.2018.02.026. Epub 2018 Feb 27. Exp Gerontol. 2018. PMID: 29499373
-
Evaluation of elevated serum liver enzymes and metabolic syndrome in the PERSIAN Guilan cohort study population.Heliyon. 2024 Jun 5;10(11):e32449. doi: 10.1016/j.heliyon.2024.e32449. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38961895 Free PMC article.
-
Association between liver enzymes and metabolic syndrome: a study in Bangladeshi adults.Expert Rev Endocrinol Metab. 2023 Sep-Nov;18(6):541-547. doi: 10.1080/17446651.2023.2272867. Epub 2023 Nov 28. Expert Rev Endocrinol Metab. 2023. PMID: 37873597
-
Serum liver enzymes and metabolic syndrome from the Rafsanjan Cohort Study.J Investig Med. 2023 Feb;71(2):140-148. doi: 10.1177/10815589221141830. Epub 2023 Jan 16. J Investig Med. 2023. PMID: 36647299
-
Metabolic syndrome and transaminases: systematic review and meta-analysis.Diabetol Metab Syndr. 2023 Oct 30;15(1):220. doi: 10.1186/s13098-023-01200-z. Diabetol Metab Syndr. 2023. PMID: 37899468 Free PMC article. Review.
Cited by
-
Exploratory analysis of the variable response to an intensive lifestyle change program for metabolic syndrome.BMC Prim Care. 2024 Oct 1;25(1):357. doi: 10.1186/s12875-024-02608-w. BMC Prim Care. 2024. PMID: 39354341 Free PMC article.
-
Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort.CJC Open. 2023 Dec 16;6(2Part B):314-326. doi: 10.1016/j.cjco.2023.12.010. eCollection 2024 Feb. CJC Open. 2023. PMID: 38487056 Free PMC article.
References
-
- Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. - PubMed
-
- Canada S. Metabolic syndrome in adults, 2012 to 2013. [Internet]. 2015. https://www150.statcan.gc.ca/n1/pub/82-625-x/2014001/article/14123-eng.htm. Accessed 10 Sept 2020.
-
- Meisinger C, Döring A, Schneider A, Löwel H, Group KS Serum γ-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis. 2006;189(2):297–302. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous